Cargando…
Blood Serum Alpha Fetoprotein Enhancer Binding Protein, a Tumor Suppressor, Decreases in Chronic HBV Hepatitis Patients as Hepatocellular Cancer Appears
Chronic hepatitis increases the risk of hepatocellular carcinoma (HCC). To test whether circulating proteins reflect hepatic carcinogenesis, sera from patients and controls were albumin depleted, enriched for glycoproteins, digested with trypsin, and subjected to reverse phase chromatography and tan...
Autores principales: | Riggins, James N., Corey, William, Fonteh, Alfred N., Harrington, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833326/ https://www.ncbi.nlm.nih.gov/pubmed/20534899 http://dx.doi.org/10.3233/DMA-2010-0692 |
Ejemplares similares
-
Identification of Disease Markers in Human Cerebrospinal Fluid Using Lipidomic and Proteomic Methods
por: Fonteh, Alfred N., et al.
Publicado: (2006) -
Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022) -
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha‐fetoprotein assessment
por: Tajiri, Hitoshi, et al.
Publicado: (2016) -
Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
por: Sun, Jianping, et al.
Publicado: (2019) -
Clinical Utility of Alpha Fetoprotein and HCCR-1, Alone or in Combination, in Patients with Chronic Hepatitis, Liver Cirrhosis and Hepatocellular Carcinoma
por: Jirun, Peng, et al.
Publicado: (2011)